IEEE ISBI 2022

Clinical Day

Medical imaging plays a major role in the clinical decision-making process in oncology. Until recently, that role has been limited to radiological diagnosis and staging. However, quantitative  markers have been shown to be relevant for grading and genotyping of the tumor. These markers can be derived from routine clinical images non-invasively, as a set of intensity and texture based features generally termed Radiomics. Radiomic features have illustrated an impact not only in pathological and genotypic diagnosis of the tumor, but also in radiation treatment planning, understanding effects of chemotherapy etc.,  paving its way to become a critical entity in oncology. The main purpose of the workshop is to provide a stimulating environment for an in-depth discussion to understand the clinical and research problems to find future relevant solutions in radiomics workflow and its clinical translation.